Sunshine Act Meetings

Citation86 FR 67740
Record Number2021-26015
Published date29 November 2021
SectionNotices
CourtNuclear Regulatory Commission
67740
Federal Register / Vol. 86, No. 226 / Monday, November 29, 2021 / Notices
Document ADAMS accession No.
NUREG–2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope
Production Facility, dated October, 2015. ML15288A046.
Construction Permit No. CPMIF–001 for the SHINE Medical Isotope Production Facility, dated February 29, 2016 ML16041A473.
SHINE Medical Technologies, LLC’s Revisions to Final Safety Analysis Report, Chapter 4, Irradiation Unit and Ra-
dioisotope Production Facility Description, Rev. 1, dated March 23, 2021. ML21095A226.
SHINE Medical Technologies, LLC’s Revisions to Final Safety Analysis Report, Chapter 9, Auxiliary Systems,
Rev. 0, dated March 23, 2021. ML21095A225.
SHINE Medical Technologies, LLC, Request to Amend Construction Permit No. CPMIF–001, dated April 29, 2021 ML21119A165 (Package).
SHINE Medical Technologies, LLC, Request to Amend Construction Permit No. CPMIF–001 Response to Request
for Additional Information, dated August 20, 2021. ML21242A028 (Package).
Dated: November 23, 2021.
For the Nuclear Regulatory Commission.
Joshua M. Borromeo,
Chief, Non-Power Production and Utilization
Facility Licensing Branch, Division of
Advanced Reactors and Non-Power
Production and Utilization Facilities, Office
of Nuclear Reactor Regulation.
[FR Doc. 2021–25911 Filed 11–26–21; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2021–0001]
Sunshine Act Meetings
TIME AND DATE
: Weeks of November 29,
December 6, 13, 20, 27, 2021, January 3,
2022.
PLACE
: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS
: Public.
MATTERS TO BE CONSIDERED
:
Week of November 29, 2021
There are no meetings scheduled for
the week of November 29, 2021.
Week of December 6, 2021—Tentative
Tuesday, December 7, 2021
10:00 a.m. Briefing on Equal
Employment Opportunity,
Affirmative Employment, and Small
Business (Public Meeting) (Contact:
Larniece McKoy Moore: 301–415–
1942)
Additional Information: The public is
invited to attend the Commission’s
meeting live by webcast at the Web
address—https://video.nrc.gov/. For
those who would like to attend in
person, note that all visitors are required
to complete the NRC Self-Health
Assessment and Certification of
Vaccination forms. Visitors who certify
that they are not fully vaccinated or
decline to complete the certification
must have proof of a negative Food and
Drug Administration-approved
polymerase chain reaction (PCR) or
Antigen (including rapid tests) COVID–
19 test specimen collection from no
later than the previous 3 days prior to
entry to an NRC facility. The forms and
additional information can be found
here https://www.nrc.gov/about-nrc/
covid-19/guidance-for-visitors-to-nrc-
facilities.pdf.
Thursday, December 9, 2021
9:00 a.m. Briefing on 10 CFR part 53
Licensing and Regulations of
Advanced Nuclear Reactors (Public
Meeting) (Contact: Donna Williams:
301–415–1322)
Additional Information: The public is
invited to attend the Commission’s
meeting live by webcast at the Web
address—https://video.nrc.gov/. For
those who would like to attend in
person, note that all visitors are required
to complete the NRC Self-Health
Assessment and Certification of
Vaccination forms. Visitors who certify
that they are not fully vaccinated or
decline to complete the certification
must have proof of a negative Food and
Drug Administration-approved PCR or
Antigen (including rapid tests) COVID–
19 test specimen collection from no
later than the previous 3 days prior to
entry to an NRC facility. The forms and
additional information can be found
here https://www.nrc.gov/about-nrc/
covid-19/guidance-for-visitors-to-nrc-
facilities.pdf.
Week of December 13, 2021—Tentative
There are no meetings scheduled for
the week of December 13, 2021.
Week of December 20, 2021—Tentative
There are no meetings scheduled for
the week of December 20, 2021.
Week of December 27, 2021—Tentative
There are no meetings scheduled for
the week of December 27, 2021.
Week of January 3, 2022—Tentative
There are no meetings scheduled for
the week of January 3, 2022.
CONTACT PERSON FOR MORE INFORMATION
:
For more information or to verify the
status of meetings, contact Wesley Held
at 301–287–3591 or via email at
Wesley.Held@nrc.gov. The schedule for
Commission meetings is subject to
change on short notice.
The NRC Commission Meeting
Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.,
braille, large print), please notify Anne
Silk, NRC Disability Program Specialist,
at 301–287–0745, by videophone at
240–428–3217, or by email at
Anne.Silk@nrc.gov. Determinations on
requests for reasonable accommodation
will be made on a case-by-case basis.
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555, at
301–415–1969, or by email at
Tyesha.Bush@nrc.gov or Betty.Thweatt@
nrc.gov.
The NRC is holding the meetings
under the authority of the Government
in the Sunshine Act, 5 U.S.C. 552b.
Dated: November 24, 2021.
For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2021–26015 Filed 11–24–21; 11:15 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket Nos. 52–025 and 52–026; NRC–
2008–0252]
Southern Nuclear Operating Company,
Inc.; Vogtle Electric Generating Plant
Units 3 and 4
AGENCY
: Nuclear Regulatory
Commission.
ACTION
: Exemption; issuance.
VerDate Sep<11>2014 16:55 Nov 26, 2021 Jkt 256001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\29NON1.SGM 29NON1
khammond on DSKJM1Z7X2PROD with NOTICES

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT